These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 8702845)
1. The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain. Lee FJ; Pristupa ZB; Ciliax BJ; Levey AI; Niznik HB J Biol Chem; 1996 Aug; 271(34):20885-94. PubMed ID: 8702845 [TBL] [Abstract][Full Text] [Related]
2. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884 [TBL] [Abstract][Full Text] [Related]
3. Substrate transport and cocaine binding of human dopamine transporter is reduced by substitution of carboxyl tail with that of bovine dopamine transporter. Lee SH; Cho HK; Son H; Lee YS Neuroreport; 1997 Jul; 8(11):2591-4. PubMed ID: 9261833 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding. Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271 [TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains. Lin Z; Wang W; Uhl GR Mol Pharmacol; 2000 Dec; 58(6):1581-92. PubMed ID: 11093799 [TBL] [Abstract][Full Text] [Related]
6. Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition. Lin Z; Wang W; Kopajtic T; Revay RS; Uhl GR Mol Pharmacol; 1999 Aug; 56(2):434-47. PubMed ID: 10419565 [TBL] [Abstract][Full Text] [Related]
7. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine. Chen N; Zhen J; Reith ME J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185 [TBL] [Abstract][Full Text] [Related]
8. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter. Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a recombinant human dopamine transporter in multiple cell lines. Eshleman AJ; Neve RL; Janowsky A; Neve KA J Pharmacol Exp Ther; 1995 Jul; 274(1):276-83. PubMed ID: 7616409 [TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter transmembrane domain polar mutants: DeltaG and DeltaDeltaG values implicate regions important for transporter functions. Itokawa M; Lin Z; Cai NS; Wu C; Kitayama S; Wang JB; Uhl GR Mol Pharmacol; 2000 Jun; 57(6):1093-103. PubMed ID: 10825379 [TBL] [Abstract][Full Text] [Related]
11. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue. Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005 [TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Kitayama S; Shimada S; Xu H; Markham L; Donovan DM; Uhl GR Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7782-5. PubMed ID: 1502198 [TBL] [Abstract][Full Text] [Related]
13. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167 [TBL] [Abstract][Full Text] [Related]
14. The interaction of methylphenidate and benztropine with the dopamine transporter is different than other substrates and ligands. Dar DE; Mayo C; Uhl GR Biochem Pharmacol; 2005 Aug; 70(3):461-9. PubMed ID: 15950948 [TBL] [Abstract][Full Text] [Related]
15. Importance of valine at position 152 for the substrate transport and 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane binding of dopamine transporter. Lee SH; Chang MY; Lee KH; Park BS; Lee YS; Chin HR; Lee YS Mol Pharmacol; 2000 May; 57(5):883-9. PubMed ID: 10779370 [TBL] [Abstract][Full Text] [Related]
16. Expression and regulation of the human dopamine transporter in a neuronal cell line. Zhang L; Elmer LW; Little KY Brain Res Mol Brain Res; 1998 Aug; 59(1):66-73. PubMed ID: 9729282 [TBL] [Abstract][Full Text] [Related]
17. The region of dopamine transporter encompassing the 3rd transmembrane domain is crucial for function. Lee SH; Kang SS; Son H; Lee YS Biochem Biophys Res Commun; 1998 May; 246(2):347-52. PubMed ID: 9610361 [TBL] [Abstract][Full Text] [Related]
18. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression. Lin Z; Itokawa M; Uhl GR FASEB J; 2000 Apr; 14(5):715-28. PubMed ID: 10744628 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, structure, dopamine transporter affinity, and dopamine uptake inhibition of 6-alkyl-3-benzyl-2-[(methoxycarbonyl)methyl]tropane derivatives. Lomenzo SA; Izenwasser S; Katz JL; Terry PD; Zhu N; Klein CL; Trudell ML J Med Chem; 1997 Dec; 40(26):4406-14. PubMed ID: 9435910 [TBL] [Abstract][Full Text] [Related]
20. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding. Rothman RB; Dersch CM; Carroll FI; Ananthan S Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]